Top 5 Stock Picks of Glenn Greenberg’s Brave Warrior Capital

Page 5 of 5

1. Elevance Health Inc. (NYSE:ELV)

Brave Warrior Capital’s Stake Value: $584,538,000

Percentage of  Brave Warrior Capital’s 13F portfolio: 20.06%

Number of  Hedge Fund Holders: 74

Elevance Health Inc. (NYSE:ELV), formerly known as Anthem, Inc., is a health benefits provider. It assists consumers, families, and communities along the care journey by linking them to the care, support, and resources they need to live healthy lives.

Among the hedge funds tracked by Insider Monkey, 74 funds were bullish on Elevance Health Inc. (NYSE:ELV) in Q2 2022, with a collective stake of around $5.22 billion. Jean-Marie Eveillard’s First Eagle Investment Management is a major shareholder of the company, with more than 2.01 million shares worth $970 million.

Here is what Baron Health Care Fund has to say about Elevance Health Inc. (NYSE:ELV) in its Q1 2022 investor letter:

“We initiated a position in Anthem, Inc. (NYSE:ANTM) (which recently announced plans to change its name to Elevance Health Inc. (NYSE:ELV)), one of the largest health benefits companies in the U.S. in terms of medical membership, serving more than 45 million medical members through its affiliated health plans. Anthem serves its members through the Blue Cross and Blue Shield brand name. Similar to many managed care peers, Anthem generates its revenue from the U.S. (which avoids risks related to foreign country exposure) and has pricing power (which enables it to more than offset inflation). More specific to Anthem, the company has multiple growth drivers, including its Medicare Advantage business, its in-house pharmacy benefit management business, and its Diversified Business Group, which includes behavioral health, advanced analytics, and complex and chronic care services. Over the long term, management targets 12% to 15% annual EPS growth. We think Anthem is a high-quality growth company trading at a reasonable valuation.”

You can also take a look at the Top 10 Stock Picks of Mark Kleiman’s Factorial Partners and Top 10 Stock Picks of Minerva Advisors.

Page 5 of 5